 | |
| Company type | private |
|---|---|
| Founded | 2009 |
| Founder | Róbert Wessman |
| Headquarters | Pine Brook, New Jersey[1] |
| Revenue |  $1.1 billion (2017) |
| Owners | CVC Capital Partners and Temasek Holdings |
Number of employees | 2800 |
| Website | www |
Alvogen is an Icelandic pharmaceutical company founded in 2009. In 2014, a controlling stake in the company was acquired by CVC Capital Partners and Temasek Holdings. Alvogen has about 350 different medical and non-medical products, and both produces its own products and markets the products of brand name pharmaceutical companies.
Its sister company Alvotech produces biosimilars.
- ^ "Company Overview of Alvogen, Inc". Bloomberg. Retrieved 21 July 2018.